Biotech | April 28, 2022
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
This facility will design & develop instruments, perform product reliability performance testing and verification
Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
Subscribe To Our Newsletter & Stay Updated
